http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02062356-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_812aff396587499a1443e3ef14ae0082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6ee2d03d331a902b9c8f0f91612f956
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6923
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
filingDate 2002-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd2f0fb4fee9301f6dcde65d212bde3b
publicationDate 2002-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-02062356-A3
titleOfInvention Monovalent-selective cation exchangers as oral sorbent therapy
abstract The present invention relates to compounds and methods of treating patients exhibiting high levels serum toxins. The present invention finds particularly advantageous use for patients suffering from renal and/or liver dysfunction. The present invention includes administering to such patients a zirconium-silicate sorbent in amounts sufficient to reduce one or more of the levels of the serum toxins. The zirconium-silicate sorbent can function as a cation exchanger and exchange one or more cations and adsorb cationic toxics, such as, ammonium cations, potassium cations, sodium cations, calcium cations, magnesium cations, from the patient. Additionally, the zirconium-silicate sorbent can be combined with one or more of a carbon agent (or charcoal), zinc oxide and/or agent to enhance the intestine permeability such as a non absorbable alcohol.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8986669-B2
priorityDate 2001-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4581141-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6099737-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6332985-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44544175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454240392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581

Total number of triples: 30.